Full name
"HAL ALLERGY" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.90.Z - Non-specialized wholesale trade
58.19.Z - Other publishing activities, excluding software publishing
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
82.99.Z - Other business support activities, not elsewhere classified
86.90.Z - Other healthcare activities
45.11.Z
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | -1,3 | 1 | 176,6 |
Gross profit (loss) | 0,6 | 0,4 | 0,9 | 116,9 |
EBITDA | 0,7 | 0,5 | 0,9 | 107,8 |
Short time liabilities | 11,6 | 16,2 | 7,5 | -53,8 |
Other operating costs | 0,2 | 0 | 0,1 | -∞ |
Equity capital | 2,9 | 3,3 | 3,9 | 18,1 |
Operating profit (EBIT) | 0,6 | 0,4 | 0,9 | 113,6 |
Assets | 16,4 | 19,7 | 11,5 | -41,4 |
Net profit (loss) | 0,3 | 0,4 | 0,6 | 42,7 |
Cash | 2,2 | 4,4 | 1,7 | -60,1 |
Net income from sale | 21,6 | 24,9 | 26,3 | 5,8 |
Liabilities and provisions for liabilities | 13,5 | 16,4 | 7,7 | -53,4 |
Working assets | 16,2 | 19,6 | 11,4 | -41,6 |
Other income costs | 0,1 | 1,7 | 0,1 | -95,7 |
Depreciation | 0 | 0 | 0 | 10,8 |
% | % | % | p.p. | |
Profitability of capital | 9,3 | 12,7 | 15,4 | 2,7 |
Equity capital to total assets | 17,5 | 16,7 | 33,6 | 16,9 |
Gross profit margin | 2,9 | 1,7 | 3,5 | 1,8 |
EBITDA Margin | 3,1 | 1,8 | 3,6 | 1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 197 | 238 | 104 | -134 |
Current financial liquidity indicator | 1.3944839239120483 | 1.2063552141189575 | 1.523313045501709 | 0,3 |
Net dept to EBITDA | -0.21677204966545105 | -8.398153305053711 | -1.6202385425567627 | 6,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane